Bhubaneswar, January 28, 2022 - ICMR approved the Rapid Antigen Test kit for SARS-CoV-2 co-developed by IMGENEX India and RMRC, Bhubaneswar - the first such kit from a company in Odisha and the Eastern Zone of India.
Read moreIMGENEX India received a 3-year Phase II grant under the BIRAC scheme of the Government of India to develop biosimilar Herceptin (Trastuzumab) for the treatment of breast cancer.
Read moreAt Imgenex India laboratory, a formulation was made using bacterial cell lysate that helps reduce vat dyes at room temperature - which earlier was not possible without heat.
Read moreICMR released the indigenous diagnostic kit to detect common Indian beta-thalassemia mutations, manufactured by IMGENEX India in collaboration with the National Institute of Immunohematology, Mumbai.
Read moreIMGENEX India in collaboration with Indian Agricultural Research Institute, New Delhi was awarded a grant from BIRAC to develop detection kits for plant viruses affecting horticultural crops.
Read more
IMGENEX INDIA Pvt. Ltd. was awarded as an Emerging Company of the Year 2015 under Bio Industrial category at Bangalore India Bio - the biggest biotech event in India.
Read more
BioSpectrum Asia (Singapore) chose IMGENEX India for the 3rd BioSpectrum Asia-Pacific Emerging Company of the Year Award 2011 for innovative work in osteoporosis with high potential impact.
Read more